Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT04011904
Eligibility Criteria:
Inclusion Criteria:
* Participants who have provided written informed consent
* Age between 18 and 80 years
* Homozygous carriers of the nonsense p.Arg684Ter variant in the TBC1D4 gene (cases)
* Homozygous non-carriers of the nonsense p.Arg684Ter variant in the TBC1D4 gene (control)
Exclusion Criteria:
* If study participants do not want to know whether they are carriers or non-carriers of the p.Arg684Ter variant in the TBC1D4 gene they will not be able to participate in the study
* BMI ≥ 18.5 kg/m2
* Diagnosis of diabetes (HbA1c ≥ 6,5% (48 mmol/mol)) or pharmacological treatment of diabetes (10).
* Use of peroral glucocorticoids
* Lack of compliance with the procedures in the study protocol, judged by Investigator
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04011904
Study Brief:
Protocol Section:
NCT04011904